Larry Todd Edwards, SVP Chief Commercial Officer at Arcutis Biotherapeutics, Inc. (ARQT), sold 3,725 shares at $10.01 ($37K) on 2024-10-02, disclosed to the SEC on 2024-10-03.
Open-market sale of $37k ARQT by SVP Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ARQT | SELL | 2025-11-10 | $1.5M | — | Filing → |
| ARQT | SELL | 2025-10-06 | $174K | — | Filing → |
| ARQT | SELL | 2025-05-20 | $210K | — | Filing → |